Melanomamobil
MelanomaMobil (branded as MelanomaMobil') is a skin cancer and mole screening service offering fullbody mole mapping and dermatoscopic analysis to detect melanoma and other skin cancers at the earliest stages. It records and monitors every mole over time using comparative imaging, analysed by experienced dermatologists, to identify even subtle changes that may indicate malignancy.Overview
Founded Year:
Founder:
Purpose: To provide early melanoma detection through thorough mole mapping and specialist evaluation, with the aim of identifying malignancies before they progress to advanced disease.
Governing Body
Organisation Name: MelanomaMobil
Company Status: Commercial private skin screening service provider
Regulatory Status:
- Not a statutory regulator
- Operates as a private skin cancer screening clinic (details of formal accreditation such as CQC lacking publicly available data)
Industry Standing: Known as a specialist mole screening service with a focus on comparative mole analysis, with thousands of screenings completed to date.
Eligibility Criteria
Who Can Apply: Individuals seeking professional mole and skin cancer screening (adults and accompanying minors up to age 16 with adults)
Requirements:
Appointment booking requiredParticipation in clinical screening procedures sup...Provision of personal health information for the s...
Restrictions:
Service is not a licence or statutory medical cert...Patients must attend clinic locations where the se...
Judging Criteria
Evaluation Factors:
Comparative assessment of mole images over timeDermatologist review of dermatoscopic imageryIdentification of suspicious changes in moles that may indicate melanoma
Categories
Available Categories:
Initial full body mole check with mole mappingFollow‑up comparative mole screening examination
Accreditation Requirements
Inspection Required: There is no publicly available indication that an external statutory inspection (such as CQC) accredits this service, though clinical procedures are conducted by licensed clinicians.
Documentation Required:
Clinical imaging data gathered during mole mappingComparative records for follow‑up assessments
Compliance Standards:
Internal clinical and imaging protocols for early ...
Sources:
Verification Process
Public Register:
Certificate Validation Method:
- Not applicable MelanomaMobil does not issue licenses or certificates of accreditation
- Service validation is based on clinical screening reports provided to patients.
Sources:
Renewal & Compliance
Renewal Frequency:
CPD Requirements:
Audit Process:
- Clinical quality oversight is handled internally
- External regulatory audits are not publicly documented.
Sources:
Benefits
Reputation: Recognised by patients seeking specialist mole screening beyond primary care access, with patient testimonials describing successful early detection experiences.
Patient Trust Impact: Patients may be reassured by comprehensive imaging and specialist dermatological review, potentially increasing early detection and trust in the process.
Patient Safety Impact
Mechanisms of Protection:
Full body mole mapping and comparative analysis highlights early changes that may be missed by visual inspection alone.Dermatologist evaluation of dermatoscopically captured images enhances detection accuracy.
Limitations:
Service is a clinical screening provider and not a statutory healthcare regulator.Screening does not replace comprehensive medical care from NHS or regulated health systems.
Comparison with Other Bodies
Comparable Entities:
NHS skin cancer screening pathways via GP and dermatology referralPrivate dermatology clinics offering skin cancer checksDigital melanoma risk assessment apps (e.g., SkinVision)
Key Differences:
MelanomaMobil specialises in mole mapping and longitudinal comparative analysis, which may not be the standard focus of general dermatology clinics.Unlike digital apps, MelanomaMobil includes clinician evaluation and specialist dermatology review.
Industry Recognition
Media Mentions:
Patient reviews and specialist service descriptions highlight experiences with MelanomaMobil screening.
Endorsements:
Credibility Signals:
Service models claim thousands of mole checks completed and specialist clinician involvement.
Government Regulation Status
Statutory Backing:
Regulated By:
Legal Status:
- Operates as a private clinical service
- Does not have statutory regulatory accreditation publicly documented.
